NICE recommends annual MRI screenings for breast cancer
Guidelines updated for high-risk women aged between 20-49 years.
Women's health
Agfa HealthCare launches new digital mammography functionality within IMPAX™
At RSNA, Agfa HealthCare introduced a range of functional extensions for digital mammography reading and reporting applications on its industry leading IMPAX™ PACS platform. The company launched IMPAX 6.2 integrated with CAD and MRS® Reporting as well as showing a work-in-progress of a new software application that addresses the growing need for digital mammography screening.
EU challenge to worldwide BRCA2 gene patent
An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.
Mammography screening arrives in Germany
The Kassenärztliche Vereinigungen (regional Associations of Statutory Health Insurance Physicians) are inviting women aged 50-69 years for mammography screening and, slowly but surely, the appointment books of the centres that perform this early detection examination are filling.
Into the breast's depths
USA - Radiologists at Newton-Wellesley Hospital in Newton, Massachusetts have released findings from a breast cancer research study designed to evaluate the use of software from Advanced Image Enhancement, Inc (AIE) for examining regions of interest (ROI) with Hologic's Lorad Selenia digital mammography system.
CTLM Seeing through the dense breast
Optical imaging stands on the threshold of a vast array of imaging uses, writes Professor Eric N C Milne MD FRCR FRCP, Professor Emeritus of Radiology and Medicine, University of California Irvine, and Director of Clinical Research, Imaging Diagnostic Systems Inc. `Presently, its greatest worth lies in higher sensitivity for the dense breast. It detects many more occult cancers than conventional…
DMIST demystified
Cynthia E Keen discusses the controversy evoked by an ambitious 36-month digital mammography trial that has cost the US $26,000,000
Mammography
Immobilisation of the female breast for diagnostic examination and biopsy is one of the prime foci of the Noras Company.
Back on the map
In September 2002, when Philippe Houssiau became President of Agfa's HealthCare Business Group, he quickly saw that the company possessed huge imaging technology and knowledge that could be focused on producing new products and solutions.
BREAST THERAPIES
Ballon Brachytherapy and effective drug combination.
Automated screening & reduced biopsies
Although X-ray mammography can detect small cancers before they have spread. However, because abnormalities can only be identified non-specifically, percutaneous or surgical breast biopsy must follow - but less than 20% of women recalled for biopsies have cancer.
First EU Women's Healthcare Centre opens
The Diagnostic Breast Centre Gottingen has opened the first European Women's Healthcare Centre (WHC). Professor Uwe Fischer, head of the new centre, said: "We have set ourselves the objective, with the help of ultra-modern systems and high-quality processes, to diagnose breast cancer in the very earliest stages."
